**Core Concept**
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), a class of antiretroviral drugs that work by inhibiting the reverse transcriptase enzyme, which is essential for the replication of retroviruses such as HIV.

**Why the Correct Answer is Right**
NRTIs, like lamivudine, act as chain terminators by incorporating into the growing viral DNA strand and causing premature chain termination. They work by binding to the active site of the reverse transcriptase enzyme, preventing the incorporation of nucleotides into the viral DNA. This mechanism is specific to NRTIs and is distinct from other classes of antiretroviral drugs, such as non-nucleoside reverse transcriptase inhibitors (NNRTIs) or protease inhibitors.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because lamivudine is not a protease inhibitor, which is a different class of antiretroviral drugs that work by inhibiting the protease enzyme, essential for the maturation of viral particles.
* **Option B:** This option is incorrect because lamivudine is not a fusion inhibitor, which is a class of antiretroviral drugs that work by inhibiting the fusion of viral particles with host cells.
* **Option C:** This option is incorrect because lamivudine is not an entry inhibitor, which is a class of antiretroviral drugs that work by inhibiting the entry of viral particles into host cells.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that NRTIs, like lamivudine, can cause mitochondrial toxicity, which can manifest as lactic acidosis, a potentially life-threatening condition. This is a critical consideration when prescribing NRTIs, especially in patients with pre-existing mitochondrial disorders.

**Correct Answer: C. Lamivudine belongs to the Nucleoside Reverse Transcriptase Inhibitor (NRTI) type of antiretroviral group of drugs.**